Evaluation of Nucleus 6 Sound Coding Algorithms

NCT01854879 | Completed Results DMC

• 1 other identifier: CT004
• Study Type: interventional
• Target: 97
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of the study was to evaluate the features of the Nucleus 6 Sound Processor (CP900 series) on existing Nucleus recipients who currently use the previous generation sound processor, the Cochlear Nucleus CP810 (also commonly known as the Nucleus 5), with a Cochlear Nucleus CI24RE, CI512 or CI422 cochlear implant. The features evaluated included an enhanced Automatic Gain Control (eAGC), the option to provide acoustic amplification in combination with traditional electric stimulation through an acoustic component, and three input processing algorithms: Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN). As is customary for a single-subject research design, study results will be analyzed for each subject individually. For evaluations where testing took place under two conditions (i.e. Endpoint 2, 3, 4, and 5) a non-inferiority hypothesis test based on the paired comparisons of the % of words correct will be performed. For each subject, the paired difference (P1 minus P2) will be calculated and the mean difference will be tested statistically against a non-inferiority null hypothesis of 10%. Successful rejection of the null hypothesis allows for a conclusion that the performance under the test condition 2 (based on the Nucleus 6 sound processor) will be non-inferior to the test condition 1 (based on the Nucleus 5 sound processor). Ho: P1 - P2 ≥ 10% Ha: P1 - P2 \< 10% We hypothesize acceptance of the null hypothesis for the Nucleus 6 features. Testing will be based on a paired t-test with a one-sided 0.05 alpha level. The value of 10% was selected as the non-inferiority margin as one that can be tested with reasonable power and was clinically meaningful.

Conditions

Hearing Loss

Keywords

background noise; speech performance; wind noise

Outcome Measures

Primary Outcomes (1)

• Percentage of Words Correct on AzBio Sentences in Noise S0N90

  Individuals were tested with AzBio Sentences in Noise using a speech front (0 degrees) and noise presented to the implant ear (90 degrees) using the following features: enhanced Automatic Gain Control (eAGC), Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).

  Each assessment was completed acutely which equated to approximately 2 hours of testing

Study Arms (1)

Nucleus 6

EXPERIMENTAL

Device: Nucleus 6 sound processor

Interventions

Nucleus 6 sound processor DEVICE

Nucleus 6

Eligibility Criteria

• Age: 8 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Eight years of age or older
• CI24RE, CI500 or CI422 series Nucleus cochlear implant types (commercially approved)
• At least 3 months experience with the cochlear implant
• Post-linguistic onset of bilateral sensorineural hearing loss, with no congenital component to the hearing loss
• Native speaker of English, the language used to assess speech perception performance
• Willingness to participate in and to comply with all requirements of the protocol

You may not qualify if:

• \. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the prosthetic device 2. Unwillingness or inability of the candidate to comply with all investigational requirements 3. Additional handicaps that would prevent or restrict participation in the audiological evaluations

Sponsors & Collaborators

• Cochlear: lead

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing Disorders; Ear Diseases; Otorhinolaryngologic Diseases; Sensation Disorders; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Results Point of Contact

• Title: Lori O'Neill Director of Research
• Organization: Cochlear Americas

loneill@cochlear.com

(303) 790-9010

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 13, 2013
• First Posted: May 16, 2013
• Study Start: March 1, 2013
• Primary Completion: May 1, 2013
• Study Completion: May 1, 2013
• Last Updated: November 23, 2020
• Results First Posted: November 4, 2020

Record last verified: 2020-11